Literature DB >> 2545036

Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus.

M D Goldsborough1, D DiSilvestre, G F Temple, A T Lorincz.   

Abstract

The nucleotide sequence of human papillomavirus (HPV) 31 DNA (7912 bp) was determined and used to deduce the genomic organization of this cervical cancer-associated virus. Based on comparisons of the HPV 31 DNA sequence to other sequenced HPVs, HPV 31 is a typical papillomavirus most related to HPV 16 (70% identical nucleotides). The E6 and E7 open reading frames (ORF) of HPV 31 contain several potential DNA binding motifs (Cys-X-X-Cys), the locations of which are conserved in all HPVs. The E6 ORF also has the potential to code for an E6* protein. The E7 ORF of HPV31 encodes a polypeptide motif which appears to distinguish HPVs associated with cervical cancer, such as types 16, 18, 31, and 33, from HPVs found primarily in benign lesions, such as types 6 and 11.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545036     DOI: 10.1016/0042-6822(89)90545-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  Nucleotide sequence-based multitarget identification.

Authors:  T Vinayagamoorthy; Kirk Mulatz; Roger Hodkinson
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions.

Authors:  A J van den Brule; P J Snijders; P M Raaphorst; H F Schrijnemakers; H Delius; L Gissmann; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Persistence of newly detected human papillomavirus type 31 infection, stratified by variant lineage.

Authors:  Long Fu Xi; Mark Schiffman; Laura A Koutsky; Zhonghu He; Rachel L Winer; Ayaka Hulbert; Shu-Kuang Lee; Yang Ke; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2012-07-11       Impact factor: 7.396

5.  A highly conserved nucleotide string shared by all genomes of human papillomaviruses.

Authors:  J Campione-Piccardo; M L Montpetit; L Grégoire; M Arella
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

6.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

7.  A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

9.  Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33.

Authors:  M Evander; E Bodén; L Bjersing; E Rylander; G Wadell
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction.

Authors:  Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.